Stroke: Effect of implementing an evaluation and treatment protocol compliant with NINDS recommendations.

PURPOSE To evaluate--relative to routine clinical practice--the potential cost-effectiveness of implementing a strategy compliant with National Institute of Neurological Disorders and Stroke (NINDS) recommendations for care of patients presenting with signs and symptoms of acute ischemic stroke. MATERIALS AND METHODS A discrete-event simulation model of the process of stroke care from symptom onset through administration of tissue plasminogen activator (tPA) was constructed. A literature review was performed to determine process times, performance of computed tomography (CT), health outcomes, and cost estimates. The following were compared: (a) a "base-case" strategy determined on the basis of findings in the literature and (b) a NINDS-compliant strategy (ie, evaluation by emergency physician in less than 10 minutes, interpretation of CT scans within 45 minutes, and administration of tPA within 1 hour after presentation). Strategies were compared with regard to cost and effectiveness. Sensitivity analyses were performed for all relevant cost, timing, and resource parameters. Outcomes of concern were quality-adjusted life years and number of patients treated within a 3-hour therapeutic window. RESULTS The NINDS-compliant strategy resulted in an average quality-adjusted life years value of 3.64, versus 3.63 for the base case, at an approximate cost of 434 US dollars per patient. The NINDS-compliant strategy increased the proportion of treatable patients from 1.4% to 3.7% and remained cost-effective for expenditures of up to 450 US dollars per patient. Assuming base-case parameters are used, increasing the number of CT scanners from two to eight raised the proportion of treatable patients to 1.5%. Increasing the number of available neurologists from four to eight raised the proportion to 1.44%. Reducing the time from stroke onset to emergency department arrival by 30 minutes raised the proportion to up to 7.7%. CONCLUSION Applying NINDS recommendations is potentially cost-effective, although reducing the time from stroke onset to emergency department arrival may be even more so.

[1]  M. Lipton Intracranial aneurysms. , 1997, The New England journal of medicine.

[2]  Peter P. Wakker,et al.  The Utility of Health States After Stroke: A Systematic Review of the Literature , 2001, Stroke.

[3]  G. Hankey,et al.  Streptokinase for acute ischemic stroke with relationship to time of administration: Australian Streptokinase (ASK) Trial Study Group. , 1996, Journal of the American Medical Association (JAMA).

[4]  S. Hallan,et al.  Quality of life after cerebrovascular stroke: a systematic study of patients’ preferences for different functional outcomes , 1999, Journal of internal medicine.

[5]  K. Welch,et al.  Total quality improvement method for reduction of delays between emergency department admission and treatment of acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. , 1997, Archives of neurology.

[6]  J. Kostis,et al.  Delay in presentation and evaluation for acute stroke : Stroke time registry for outcomes knowledge and epidemiology (S. T. R. O. K. E.) , 2001 .

[7]  G. Azzimondi,et al.  Variables associated with hospital arrival time after stroke: effect of delay on the clinical efficiency of early treatment. , 1997, Stroke.

[8]  J. Lee,et al.  Patient Preferences for Stroke Outcomes , 1994, Stroke.

[9]  Joseph P. Broderick,et al.  Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. , 1995 .

[10]  M. Kaste,et al.  Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II) , 1998, The Lancet.

[11]  Joseph S. Pliskin,et al.  Health Economic Evaluations: The Special Case of End-Stage Renal Disease Treatment , 2002, Medical decision making : an international journal of the Society for Medical Decision Making.

[12]  M. Hommel,et al.  Thrombolytic therapy with streptokinase in acute ischemic stroke. , 1996, The New England journal of medicine.

[13]  R. Luepker,et al.  Delayed Hospital Arrival for Acute Stroke: The Minnesota Stroke Survey , 1998, Annals of Internal Medicine.

[14]  Erry,et al.  Cost effectiveness of thrombolytic therapy with tissue plasminogen activator as compared with streptokinase for acute myocardial infarction. , 1995, The New England journal of medicine.

[15]  H. Glick,et al.  Elective surgery for asymptomatic, unruptured, intracranial aneurysms: a cost-effectiveness analysis. , 1995, Journal of neurosurgery.

[16]  W. Rosamond,et al.  Determinants of Use of Emergency Medical Services in a Population With Stroke Symptoms: The Second Delay in Accessing Stroke Healthcare (DASH II) Study , 2000, Stroke.

[17]  M. Mcgrath Cost Effectiveness in Health and Medicine. , 1998 .

[18]  R. Fogelholm,et al.  Factors delaying hospital admission after acute stroke. , 1996, Stroke.

[19]  W. Thies,et al.  Guidelines for the management of aneurysmal subarachnoid hemorrhage. A statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. , 1994, Stroke.

[20]  J. Grotta,et al.  Guidelines for Thrombolytic Therapy for Acute Stroke: a Supplement to the Guidelines for the Management of Patients with Acute Ischemic Stroke. A statement for healthcare professionals from a Special Writing Group of the Stroke Council, American Heart Association. , 1996, Stroke.

[21]  E. Nussbaum,et al.  Cost-effectiveness of carotid endarterectomy. , 1996, Neurosurgery.

[22]  M. Alberts,et al.  An analysis of time of presentation after stroke. , 1990, JAMA.

[23]  R. Knill-Jones,et al.  Observer variability in assessing impaired consciousness and coma. , 1978, Journal of neurology, neurosurgery, and psychiatry.

[24]  M. Kaste,et al.  Where and how should elderly stroke patients be treated? A randomized trial. , 1995, Stroke.

[25]  G. Chapman,et al.  [Medical decision making]. , 1976, Lakartidningen.

[26]  N A Azimi,et al.  The effectiveness of cost-effectiveness analysis in containing costs , 1998, Journal of general internal medicine.

[27]  W. Rosamond,et al.  Time delays in accessing stroke care in the emergency department. , 1999, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.

[28]  W. Rosamond,et al.  Rapid response to stroke symptoms: the Delay in Accessing Stroke Healthcare (DASH) study. , 1998, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.

[29]  J. Broderick,et al.  Urgent Therapy for Stroke: Part I. Pilot Study of Tissue Plasminogen Activator Administered Within 90 Minutes , 1992, Stroke.

[30]  P. Duncan,et al.  Defining post-stroke recovery: implications for design and interpretation of drug trials , 2000, Neuropharmacology.

[31]  R. O’Connor,et al.  Thrombolytic therapy for acute ischemic stroke: why the majority of patients remain ineligible for treatment. , 1999, Annals of emergency medicine.

[32]  S. Hallan,et al.  A decision analysis of thrombolytic therapy compared with standard therapy in acute ischaemic stroke , 1999, Journal of internal medicine.

[33]  M. Kaste,et al.  Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS) , 1995, JAMA.

[34]  A. Dávalos,et al.  Delay in neurological attention and stroke outcome. Cerebrovascular Diseases Study Group of the Spanish Society of Neurology. , 1995, Stroke.

[35]  M. Malkoff,et al.  Code stroke. An attempt to shorten inhospital therapeutic delays. , 1994, Stroke.

[36]  P A Wolf,et al.  Survival and recurrence following stroke. The Framingham study. , 1982, Stroke.

[37]  J. Streifler,et al.  Factors Associated with the Time of Presentation of Acute Stroke Patients in an Israeli Community Hospital , 1998, Neuroepidemiology.

[38]  J. Lewin,et al.  Cost-effectiveness of emergency intraarterial intracerebral thrombolysis: a pilot study. , 1995, AJNR. American journal of neuroradiology.

[39]  J R Beck,et al.  Management of Unruptured Intracranial Aneurysm in Japan , 1998, Medical decision making : an international journal of the Society for Medical Decision Making.

[40]  D K Owens,et al.  The effect of stroke and stroke prophylaxis with aspirin or warfarin on quality of life. , 1996, Archives of internal medicine.

[41]  J Lipscomb,et al.  Inpatient costs of specific cerebrovascular events at five academic medical centers. , 1996, Neurology.

[42]  M. Alexander Stroke Rehabilitation Outcome: A Potential Use of Predictive Variables to Establish Levels of Care , 1994, Stroke.

[43]  Randomised controlled trial of streptokinase, aspirin, and combination of both in treatment of acute ischaemic stroke. Multicentre Acute Stroke Trial--Italy (MAST-I) Group. , 1995, Lancet.

[44]  J. Kostis,et al.  Delay in Presentation and Evaluation for Acute Stroke: Stroke Time Registry for Outcomes Knowledge and Epidemiology (S.T.R.O.K.E.) , 1997, Stroke.

[45]  F. Mahoney,et al.  FUNCTIONAL EVALUATION: THE BARTHEL INDEX. , 2018, Maryland state medical journal.

[46]  Averill M. Law,et al.  Simulation Modeling and Analysis , 1982 .

[47]  T. Brott,et al.  Improved Reliability of the NIH Stroke Scale Using Video Training , 1994, Stroke.

[48]  P. Wester,et al.  Factors associated with delayed admission to hospital and in-hospital delays in acute stroke and TIA: a prospective, multicenter study.Seek- Medical-Attention-in-Time Study Group. , 1999, Stroke.

[49]  R. Higashida,et al.  Intra-arterial Prourokinase for Acute Ischemic Stroke: The PROACT II Study: A Randomized Controlled Trial , 1999 .

[50]  L. McCaig,et al.  National Hospital Ambulatory Medical Care Survey: 1999 emergency department summary. , 2001, Advance data.

[51]  C. Chudnofsky,et al.  Emergency physician treatment of acute stroke with recombinant tissue plasminogen activator: a retrospective analysis. , 1999, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.

[52]  Joann E D’Esposito Bureau of Labor Statistics Web Site , 2000 .

[53]  Tammy O. Tengs,et al.  Five-hundred life-saving interventions and their cost-effectiveness. , 1995, Risk analysis : an official publication of the Society for Risk Analysis.

[54]  J. Broderick,et al.  Epidemiological Characteristics of Lacunar Infarcts in a Population , 1991, Stroke.

[55]  J. Banks,et al.  Handbook of Simulation , 1998 .

[56]  J. Broderick,et al.  Acute stroke: delays to presentation and emergency department evaluation. , 1999, Annals of emergency medicine.

[57]  A. Folsom,et al.  Stroke incidence and survival among middle-aged adults: 9-year follow-up of the Atherosclerosis Risk in Communities (ARIC) cohort. , 1999, Stroke.

[58]  J. Sinacore,et al.  Stroke Inpatient Rehabilitation: A Comparison across Age Groups , 1994, Journal of the American Geriatrics Society.

[59]  W. Rosamond,et al.  Stroke symptom attribution and time to emergency department arrival: the delay in accessing stroke healthcare study. , 2000, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.

[60]  T. Olsen,et al.  The effect of a stroke unit: reductions in mortality, discharge rate to nursing home, length of hospital stay, and cost. A community-based study. , 1995, Stroke.

[61]  H. Adams,et al.  Guidelines for the management of aneurysmal subarachnoid hemorrhage. A statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. , 1994, Stroke.

[62]  A. Demchuk,et al.  Improving Delivery of Acute Stroke Therapy: The TLL Temple Foundation Stroke Project , 2002, Stroke.

[63]  P D Lyden,et al.  Guidelines for thrombolytic therapy for acute stroke: a supplement to the guidelines for the management of patients with acute ischemic stroke. A statement for healthcare professionals from a Special Writing Group of the Stroke Council, American Heart Association. , 1996, Circulation.

[64]  T O Tengs,et al.  Health-related quality of life after stroke a comprehensive review. , 2001, Stroke.

[65]  W. O'Fallon,et al.  Utilization of acute care services in the year before and after first stroke: A population-based study. , 1996, Neurology.

[66]  S. Fagan,et al.  Cost-effectiveness of tissue plasminogen activator for acute ischemic stroke. , 1999, Neurology.

[67]  GiuseppeAzzimondi,et al.  Variables Associated With Hospital Arrival Time After Stroke , 1997 .

[68]  A. Dávalos,et al.  Delay in Neurological Attention and Stroke Outcome , 1995 .

[69]  Richard P. Nathan,et al.  Sharing the Burden: Strategies for Public and Private Long-Term Care Insurance , 1994 .

[70]  S. Ebrahim Systematic review of cost-effectiveness research of stroke evaluation and treatment. , 1999, Stroke.

[71]  R. Sacco,et al.  Predictors of mortality and recurrence after hospitalized cerebral infarction in an urban community , 1994, Neurology.

[72]  Carl V. Granger,et al.  Discharge Outcome After Stroke Rehabilitation , 1992, Stroke.

[73]  S. Schappert,et al.  Ambulatory care visits to physician offices, hospital outpatient departments, and emergency departments: United States, 1997. , 1997, Vital and health statistics. Series 13, Data from the National Health Survey.

[74]  W. Rosamond,et al.  Prehospital and Emergency Department Delays After Acute Stroke: The Genentech Stroke Presentation Survey , 2000, Stroke.

[75]  Joseph H. Huber,et al.  Poststroke rehabilitation in older Americans. The Medicare experience. , 1996, Medical care.